In the article titled “Metastatic Renal Cell Carcinoma with Level IV Thrombus: Contemporary Management with Complete Response to Neoadjuvant Targeted Therapy” [1], the last sentence in the Abstract should be corrected from “We describe a case of a right-sided metastatic RCC with Level IV thrombus initially managed with Pazopanib followed by Nivolumab and Adalimumab followed by cytoreductive nephrectomy and IVC thrombectomy in the post-targeted therapy setting with complete curative response” to “We describe a case of a right-sided metastatic RCC with Level IV thrombus initially managed with neoadjuvant targeted therapy followed by cytoreductive nephrectomy and IVC thrombectomy in the post-targeted therapy setting with complete curative response”.
Corrigendum | Open Access
Corrigendum to “Metastatic Renal Cell Carcinoma with Level IV Thrombus: Contemporary Management with Complete Response to Neoadjuvant Targeted Therapy”
Received21 Oct 2019
Accepted22 Oct 2019
Published20 Nov 2019
References
A. Bhat, B. Nahar, V. Venkatramani, I. Banerjee, O. N. Kryvenko, and D. J. Parekh, “Metastatic renal cell carcinoma with level IV thrombus: contemporary management with complete response to neoadjuvant targeted therapy,” Case Reports in Urology, vol. 2019, Article ID 7102504, 5 pages, 2019.
View at: Publisher Site | Google Scholar
Copyright
Copyright © 2019 Abhishek Bhat et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.